Re: SEC Approves Final Proxy Access Rules 8/25/10 non-accelerated filer

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: SEC Approves Final Proxy Access Rules 8/25/10 non-accelerated filer

in response to

SEC Approves Final Proxy Access Rules 8/25/10 non-accelerated filer

MIKE6553

posted on Aug 23, 2011 01:30PM

Thank you Mike. Relevant info, gone un-noticed....

It appears attention should be directed to "Effective dates and companies effected" (the last bullet). Is this affected by adoption of Majority Vote?